Ingolotti, M., Schlaen, B.A., Roig Melo-Granados, E.A., Ruiz García, H. and Aguilera Partida, J.A. (2019) Azathioprine during the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study. American Journal of Case Reports, 20, 300-305. https://doi.org/10.12659/AJCR.914281

has been cited by the following article:

• TITLE: The Association of Vogt-Koyanagi-Harada Disease and Pregnancy: Role of the Obstetrician (A Case Report and Literature Review)

  AUTHORS: Bouchra Fakhir, Mohamed Hicham Abdelkhalki, Dounia Makrane, Yassir Ait Benkaddour, Karam Harou, Ahlam Bassir, Abderrahim Aboulfalah, Hamid Asmouki, Abderraouf Soummani

  KEYWORDS: Vogt-Koyanagi-Harada, Pregnancy, Systemic Disease, Autoimmune Diseases, Corticosteroids, Immunosuppressors

  JOURNAL NAME: Open Access Library Journal, Vol.11 No.1, January 22, 2024

  ABSTRACT: Introduction: Vogt-Koyanagi-Harada (VKH) disease is an autoimmune disease that can affect a multitude of organs affecting melanocytes. It is a provider of many complications, mainly ocular and cutaneous. The goal: Through a case study to discuss the impact of VKH disease on pregnancy as well as the role of the obstetrician in the management of pregnancy and disease. Observation: A 30-year-old patient who was diagnosed before her actual pregnancy. The patient was on systemic corticosteroids for disease control. The evolution of her VKH disease and the pregnancy were good. Conclusion: VKH disease has no negative impact on pregnancy outcome. Complications are possible. The best therapeutic option remains systemic corticosteroid therapy.